logo
logo

Adicet Bio, Inc. announced it raised $80 Million in an initial filing from an offering of $80 Million

Oct 09, 2019almost 6 years ago

Amount Raised

$80 Million

Redwood CityBiotechnology

Company Information

Company

Adicet Bio, Inc.

Location

1000 Bridge Parkway

Redwood City, California, United States

About

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients.

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech